期刊论文详细信息
Reproductive Biology and Endocrinology
Differences in ICSI utilization rates among states with insurance mandates for ART coverage
Pavel Zagadailov1  Kyung S. Cho2  David B. Seifer3 
[1] Clinical Outcomes Research Group, CORG LLC, 178 Meadow Brook Rd, 03753, Grantham, NH, USA;Clinical Outcomes Research Group, CORG LLC, 178 Meadow Brook Rd, 03753, Grantham, NH, USA;Department of Statistics, Columbia University, 1255 Amsterdam Ave, 10027, New York, NY, USA;Department of Obstetrics and Gynecology, Yale University School of Medicine, 333 Cedar St, 06510, New Haven, CT, USA;
关键词: Assisted reproductive technology;    In-vitro fertilization;    State insurance mandates;    Intracytoplasmic sperm injection;    Utilization rates;    Live birth rate;    Male factor;   
DOI  :  10.1186/s12958-021-00856-4
来源: Springer
PDF
【 摘 要 】

BackgroundAssisted reproductive technology (ART) insurance mandates promote more selective utilization of ART clinic resources including intracytoplasmic sperm injection (ICSI). Our objective was to examine whether ICSI utilization differs by state insurance mandates for ART coverage and assess if such a difference is associated with male factor, preimplantation genetic testing (PGT), and/or live birth rates.MethodsIn this retrospective analysis of the Centers for Disease Control (CDC) data from 2018, ART clinics in ART-mandated states (n = 8, AR, CT, HI, IL, MD, MA, NJ, RI) were compared individually to one another and with non-mandated states in aggregate (n = 42) for use of ICSI, male factor, PGT, and live birth rates. ANOVA was used to evaluate differences between ART-mandated states and non-mandated states. Individual ART-mandated states were compared using Welch t-tests. Statistical significance was determined by Bonferroni Correction.ResultsThere were significant differences in ICSI rates (%, mean ± SD) between MA (53.3 ± 21.3) and HI (90.7 ± 19.6), p = 0.028; IL (86.5 ± 18.7) and MA, p = 0.002; IL and MD (57.2 ± 30.8), p = 0.039; IL and NJ (62.0 ± 26.8), p = 0.007; between non-mandated states in aggregate (79.9 ± 19.9) and MA, p = 0.006, and NJ (62.0 ± 26.8), p = 0.02. Male factor rates of HI (65.8 ± 16.0) were significantly greater compared to CT (18.8 ± 8.7), IL (26.0 ± 11.9), MA (26.9 ± 6.6), MD (29.3 ± 9.9), NJ (30.6 ± 17.9), and non-mandated states in aggregate (29.7 ± 13.7), all p < 0.0001. No significant differences were reported for use of PGT and/or live birth rates across all age groups regardless of mandate status.ConclusionsICSI use varied significantly among ART-mandated states while demonstrating no differences in live birth rates. These data suggest that the prevalence of male factor and the presence of a state insurance mandate are not the only factors influencing ICSI use. It is suggested that other non-clinical factors may impact the rate of ICSI utilization in a given state.

【 授权许可】

CC BY   

【 预 览 】
附件列表
Files Size Format View
RO202203041492450ZK.pdf 809KB PDF download
  文献评价指标  
  下载次数:29次 浏览次数:5次